ASCT Clinical Trials
2 recruitingBiologic
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China80 enrolled1 locationNCT06793449
Recruiting
Phase 2
Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
Multiple MyelomaPrimary Plasma Cell LeukemiaExtramedullary Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology54 enrolled1 locationNCT06140966